Spherix Global Insights has released the 2026 update of Market Dynamix™: Idiopathic Inflammatory Myopathies (IIM), US, revealing a market increasingly poised for disruption as rheumatologists seek ...
Monthly IVIG reduced grade ≥2 infections from 100% pre-treatment to 33% post-treatment, yielding a 67% relative and absolute risk reduction with strong statistical significance. Baseline IgG and IgA ...
A consolidated single-infusion regimen of ublituximab demonstrated comparable drug exposure, safety, and efficacy outcomes to the currently approved regimen in adults with relapsing forms of multiple ...
The Federal Reserve raised its benchmark interest rate by 0.75 percentage point on Wednesday — the biggest hike since 1994 — to try to curtail today's record-high inflation. While the Fed is expected ...
Average mortgage rates remained relatively steady this week, after jumping to their highest levels since September 2025 the week prior. The U.S. 30-year fixed mortgage rate averaged 6.53% during the ...
Amber Barkley is a writer and editor with over 10 years of experience in topics ranging from personal finance to marketing analytics to fiction. She found her niche in personal finance in 2022, when ...
The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) ...
With over four years of experience writing in the housing market space, Robin Rothstein demystifies mortgage and loan concepts, helping first-time homebuyers and homeowners make informed decisions as ...
Combination tobevibart 300 mg + elebsiran 200 mg q4w achieved HDV RNA TND in 77% at week 72 and 88% at week 96, outperforming tobevibart monotherapy. Profound HBsAg lowering occurred with dual therapy ...
Beat average interest rates with one of the top high-yield savings accounts The average savings account yield is 0.38% as of the latest FDIC data. If you’re looking for a higher yield—one that ...
A man in his 50s with poorly controlled diabetes and chronic kidney disease presented with rapidly progressive bilateral ...
Morning Overview on MSN
A single shot just slashed dangerous cholesterol levels for a full year in a late-stage trial — a gene-silencing therapy built to replace the daily statins millions take
For the roughly 200 million people worldwide who take a statin every day, the routine is deceptively simple: swallow a pill, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results